Gilead Sciences [GILD] vs Eli Lilly and [LLY] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Gilead Sciences wins in 8 metrics, Eli Lilly and wins in 5 metrics, with 0 ties. Gilead Sciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Gilead Sciences Eli Lilly and Better
P/E Ratio (TTM) 22.78 58.12 Gilead Sciences
Price-to-Book Ratio 7.05 42.90 Gilead Sciences
Debt-to-Equity Ratio 130.79 243.61 Gilead Sciences
PEG Ratio 14.59 31.50 Gilead Sciences
EV/EBITDA 11.07 30.73 Gilead Sciences
Profit Margin 20.76% 22.67% Eli Lilly and
Operating Margin 38.49% 42.49% Eli Lilly and
EBITDA Margin 38.49% 42.49% Eli Lilly and
Return on Equity 32.65% 77.28% Eli Lilly and
Return on Assets 12.14% 16.45% Eli Lilly and
Free Cash Flow $10.31B $414.30M Gilead Sciences
Dividend Yield 2.81% 0.76% Gilead Sciences
1-Year Return 68.57% -12.36% Gilead Sciences
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Gilead Sciences vs Eli Lilly and Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Gilead Sciences vs Eli Lilly and Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...